Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Craddock

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Bone Marrow Transplantation|April 12, 2023
Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMTArnon Nagler, Myriam Labopin, Stephan Mielke, et al.
Cancer Immunology, Immunotherapy : CII|August 13, 2022
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environmentVictoria Stavrou, Livingstone Fultang, Sarah Booth, et al.
Cancer|May 25, 2022
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemiaJustin Loke, Myriam Labopin, Charles Craddock, et al.
British Journal of Haematology|April 4, 2017
Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationFrancesco Onida, Liesbeth C de Wreede, Anja van Biezen, et al.
Nature Communications|May 22, 2026
Initial leukemic epigenomic state determines hypomethylating agent responseAparna Gopal, Derek Tam, Franziska Mey, et al.
Blood|October 18, 2002
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disordersJosé A Pérez-Simón, Panagiotis D Kottaridis, Rodrigo Martino, et al.
Cancer|April 6, 2024
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation studyJustin Loke, Myriam Labopin, Charles Craddock, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q DeletionLaurent Garderet, Dimitris Ziagkos, Anja van Biezen, et al.
Leukemia Research|November 13, 2024
COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experienceGiovanna Lucchini, Elena Cozma, Aimee Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2020
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid LeukemiaCharles Craddock, Aimee Jackson, Justin Loke, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Bone Marrow Transplantation|April 12, 2023
Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMTArnon Nagler, Myriam Labopin, Stephan Mielke, et al.
Cancer Immunology, Immunotherapy : CII|August 13, 2022
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environmentVictoria Stavrou, Livingstone Fultang, Sarah Booth, et al.
Cancer|May 25, 2022
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemiaJustin Loke, Myriam Labopin, Charles Craddock, et al.
British Journal of Haematology|April 4, 2017
Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationFrancesco Onida, Liesbeth C de Wreede, Anja van Biezen, et al.
Nature Communications|May 22, 2026
Initial leukemic epigenomic state determines hypomethylating agent responseAparna Gopal, Derek Tam, Franziska Mey, et al.
Blood|October 18, 2002
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disordersJosé A Pérez-Simón, Panagiotis D Kottaridis, Rodrigo Martino, et al.
Cancer|April 6, 2024
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation studyJustin Loke, Myriam Labopin, Charles Craddock, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q DeletionLaurent Garderet, Dimitris Ziagkos, Anja van Biezen, et al.
Leukemia Research|November 13, 2024
COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experienceGiovanna Lucchini, Elena Cozma, Aimee Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2020
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid LeukemiaCharles Craddock, Aimee Jackson, Justin Loke, et al.
Pageof 17